RNAi therapeutics: a potential new class of pharmaceutical drugs
Top Cited Papers
- 1 December 2006
- journal article
- review article
- Published by Springer Nature in Nature Chemical Biology
- Vol. 2 (12) , 711-719
- https://doi.org/10.1038/nchembio839
Abstract
The rapid identification of highly specific and potent drug candidates continues to be a substantial challenge with traditional pharmaceutical approaches. Moreover, many targets have proven to be intractable to traditional small-molecule and protein approaches. Therapeutics based on RNA interference (RNAi) offer a powerful method for rapidly identifying specific and potent inhibitors of disease targets from all molecular classes. Numerous proof-of-concept studies in animal models of human disease demonstrate the broad potential application of RNAi therapeutics. The major challenge for successful drug development is identifying delivery strategies that can be translated to the clinic. With advances in this area and the commencement of multiple clinical trials with RNAi therapeutic candidates, a transformation in modern medicine may soon be realized.Keywords
This publication has 80 references indexed in Scilit:
- Gene Silencing Activity of siRNAs with a Ribo-difluorotoluyl NucleotideACS Chemical Biology, 2006
- Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic miceMolecular Therapy, 2005
- RNA interference against Hec1 inhibits tumor growth in vivoGene Therapy, 2005
- RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse modelProceedings of the National Academy of Sciences, 2005
- Structural basis for 5′-end-specific recognition of guide RNA by the A. fulgidus Piwi proteinNature, 2005
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005
- Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAsNature, 2004
- Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivoNucleic Acids Research, 2004
- Synthesis and physical and physiological properties of 4'-thioRNA: application to post-modification of RNA aptamer toward NF- BNucleic Acids Research, 2004
- Asymmetry in the Assembly of the RNAi Enzyme ComplexCell, 2003